{"protocolSection": {"identificationModule": {"nctId": "NCT02251379", "orgStudyIdInfo": {"id": "NA_00093323"}, "organization": {"fullName": "Johns Hopkins University", "class": "OTHER"}, "briefTitle": "Environmental Control as Add-on Therapy in Childhood Asthma", "officialTitle": "Environmental Control as Add-on Therapy in Childhood Asthma", "acronym": "ECATCh"}, "statusModule": {"statusVerifiedDate": "2019-11", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2014-10-01", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2018-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2018-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2014-09-22", "studyFirstSubmitQcDate": "2014-09-25", "studyFirstPostDateStruct": {"date": "2014-09-29", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2019-10-15", "resultsFirstSubmitQcDate": "2019-10-15", "resultsFirstPostDateStruct": {"date": "2019-11-04", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2019-11-08", "lastUpdatePostDateStruct": {"date": "2019-11-20", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Johns Hopkins University", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "This study evaluates the effects of adding on an environmental home intervention to standard asthma medication management on controller medication requirements among children and adolescents with asthma. The investigators hypothesize that the addition of an individually-tailored, multi-faceted Environmental Control Strategy (ECS) to guidelines-based controller medication will result in less controller medication requirement and allergic inflammation than controller medication alone among urban asthmatic children.", "detailedDescription": "The study is a parallel arm study of an individually tailored, multi-faceted ECS plus controller medication titration versus controller medication titration alone. After a 4-week run-in period to stabilize the asthma, the investigators will randomize 200 Baltimore children with persistent asthma and a recent exacerbation in a 1:1 ratio to the two arms and follow the children for six months. There will be five clinic visits and three home visits over this time period for clinical and home assessments, respectively. There will be up to four environmental intervention visits for participants randomized to the environmental control plus controller medication group. The environmental modules include mouse, cockroach, furry pets, dust mites, and smoking. Air purifiers and laundered bedding are also included in this arm. Participants randomized to the controller medication group have the option of having one home visit after completing the study at which the participants will receive home intervention services that the environmental control plus controller medication group received. Participants will have repeated assessment of: controller medication requirements; secondary clinical, physiologic, and inflammatory outcomes; and particulate matter (PM), air nicotine, and allergen levels."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 155, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "ECS + Medication Group", "type": "EXPERIMENTAL", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)", "interventionNames": ["Drug: Flovent Diskus", "Other: Home Environmental Intervention", "Drug: Advair Diskus"]}, {"label": "Medication Group Alone", "type": "ACTIVE_COMPARATOR", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)", "interventionNames": ["Drug: Flovent Diskus", "Drug: Advair Diskus"]}], "interventions": [{"type": "DRUG", "name": "Flovent Diskus", "description": "Inhaled corticosteroids", "armGroupLabels": ["ECS + Medication Group", "Medication Group Alone"], "otherNames": ["Flovent Diskus, 50 mcg, 100mcg, 250 mcg"]}, {"type": "OTHER", "name": "Home Environmental Intervention", "description": "Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding", "armGroupLabels": ["ECS + Medication Group"]}, {"type": "DRUG", "name": "Advair Diskus", "description": "inhaled corticosteroids + long-acting beta agonist", "armGroupLabels": ["ECS + Medication Group", "Medication Group Alone"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "The Medication Treatment Step Assigned", "description": "The controller medication treatment step that was assigned at the visit, which is based on the current controller medication treatment step and the current level of asthma control. The range is from 0-6, with 0 indicating no controller medication and 6 indicating high dose inhaled corticosteroids plus long-acting beta agonist.", "timeFrame": "6 month clinic visit"}], "secondaryOutcomes": [{"measure": "Daily Inhaled Corticosteroid Dose", "description": "micrograms of inhaled corticosteroids (daily)", "timeFrame": "6 months"}, {"measure": "Exhaled Nitric Oxide", "description": "Exhaled nitric oxide in parts per billion.", "timeFrame": "6 months"}, {"measure": "Number of Asthma Symptom Days", "description": "Number of asthma symptom days in the past two weeks will be a measure of asthma control.", "timeFrame": "6 months"}, {"measure": "Number of Asthma Exacerbations", "description": "Asthma exacerbations will be assessed by number of acute visits to the emergency department (ED), hospitalizations and urgent doctor visits.", "timeFrame": "6 months"}, {"measure": "FEV1/FVC", "description": "Forced expiratory volume at one second/forced vital capacity (FEV1/FVC) will be evaluated as a continuous variable. This is a ratio without any units.", "timeFrame": "6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Have physician-diagnosed asthma at least 1 year prior to the baseline visit, or asthma symptoms for at least 1 year\n* Meet criteria for current persistent asthma defined as either:\n\n  1. On a long-term controller medication for asthma, or\n  2. Meet National Asthma Education and Prevention Program (NAEPP) guideline requirements for persistent disease:(46)\n* Asthma symptoms 3 or more days per week over the past 2 weeks or\n* Nocturnal asthma symptoms at least 3 times in the past month\n* Have evidence of uncontrolled disease as defined by at least one of the following:\n\n  1. One asthma-related unscheduled visit to an emergency department (ED), clinic or urgent care facility in the previous 12 mo\n  2. One asthma-related overnight hospitalization in the previous 12 mo\n  3. One or more bursts of oral corticosteroids in the previous 12 mo\n* Reside within a geographic area of the study site so that home visits are feasible.\n* Have no plans to move within the upcoming 6 months\n* Have insurance to cover prescription medications.\n* Have a positive skin test (net wheal \u22652mm) to cat, dog, mouse, cockroach, or dust mites or have a positive cat, dog, mouse, German cockroach, or D. farinae-specific immunoglobulin E (IgE) test, as quantified using the ImmunoCAP system (\u22650.35 kU/L)\n\nExclusion Criteria:\n\n* Lung disease, other than asthma, that requires daily medication\n* Cardiovascular disease that requires daily medication, excluding hypertension\n* Taking a beta-blocker\n* Allergy to dairy\n* On Xolair \\< 5 months\n* On immunotherapy and has not reached maintenance dose\n* Sleeping in another home 4 or more nights/week\n* Active smoker defined as a positive urine screen for high levels of urine cotinine\n* Unable to access areas of home necessary to conduct extermination", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "5 Years", "maximumAge": "17 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Elizabeth C Matsui, MD MHS", "affiliation": "Johns Hopkins University", "role": "STUDY_CHAIR"}, {"name": "Meredith McCormack, MD MHS", "affiliation": "Johns Hopkins University", "role": "PRINCIPAL_INVESTIGATOR"}, {"name": "Corinne Keet, MD PHD", "affiliation": "Johns Hopkins University", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Johns Hopkins University", "city": "Baltimore", "state": "Maryland", "zip": "21287", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "FG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "77"}, {"groupId": "FG001", "numSubjects": "78"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "57"}, {"groupId": "FG001", "numSubjects": "58"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "20"}, {"groupId": "FG001", "numSubjects": "20"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "BG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "77"}, {"groupId": "BG001", "value": "78"}, {"groupId": "BG002", "value": "155"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "10.1", "spread": "3.3"}, {"groupId": "BG001", "value": "10.1", "spread": "3.3"}, {"groupId": "BG002", "value": "10.1", "spread": "3.3"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "30"}, {"groupId": "BG002", "value": "61"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "46"}, {"groupId": "BG001", "value": "48"}, {"groupId": "BG002", "value": "94"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "4"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "75"}, {"groupId": "BG001", "value": "76"}, {"groupId": "BG002", "value": "151"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "72"}, {"groupId": "BG001", "value": "67"}, {"groupId": "BG002", "value": "139"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "3"}, {"groupId": "BG002", "value": "4"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "12"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "77"}, {"groupId": "BG001", "value": "78"}, {"groupId": "BG002", "value": "155"}]}]}]}, {"title": "The treatment step assigned", "description": "The controller medication treatment step that was assigned at the visit, which is based on the current controller medication treatment step and the current level of asthma control. The range is from 0-6, with 0 indicating no controller medication and 6 indicating high dose inhaled corticosteroids plus long-acting beta agonist.", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "score on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "4.34", "spread": "1.56"}, {"groupId": "BG001", "value": "4.56", "spread": "1.57"}, {"groupId": "BG002", "value": "4.45", "spread": "1.56"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "The Medication Treatment Step Assigned", "description": "The controller medication treatment step that was assigned at the visit, which is based on the current controller medication treatment step and the current level of asthma control. The range is from 0-6, with 0 indicating no controller medication and 6 indicating high dose inhaled corticosteroids plus long-acting beta agonist.", "populationDescription": "participants completing the final 6 month follow-up visit", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "score on a scale", "timeFrame": "6 month clinic visit", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "62"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "4.03", "spread": "1.91"}, {"groupId": "OG001", "value": "4.05", "spread": "1.87"}]}]}]}, {"type": "SECONDARY", "title": "Daily Inhaled Corticosteroid Dose", "description": "micrograms of inhaled corticosteroids (daily)", "populationDescription": "participants who completed the final follow-up visit at 6 months", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "micrograms/day", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "62"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "557.5", "spread": "347.8"}, {"groupId": "OG001", "value": "527.7", "spread": "401.7"}]}]}]}, {"type": "SECONDARY", "title": "Exhaled Nitric Oxide", "description": "Exhaled nitric oxide in parts per billion.", "populationDescription": "participants completing the final follow-up visit at 6 months with valid exhaled nitric oxide measurement. Not all participants had valid measures.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "parts per billion", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "58"}, {"groupId": "OG001", "value": "61"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "20", "lowerLimit": "10", "upperLimit": "38"}, {"groupId": "OG001", "value": "20", "lowerLimit": "8", "upperLimit": "52"}]}]}]}, {"type": "SECONDARY", "title": "Number of Asthma Symptom Days", "description": "Number of asthma symptom days in the past two weeks will be a measure of asthma control.", "populationDescription": "participants who completed the final follow-up visit at 6 months.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "days", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "63"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.5", "spread": "3.2"}, {"groupId": "OG001", "value": "2.7", "spread": "3.6"}]}]}]}, {"type": "SECONDARY", "title": "Number of Asthma Exacerbations", "description": "Asthma exacerbations will be assessed by number of acute visits to the emergency department (ED), hospitalizations and urgent doctor visits.", "populationDescription": "participants completing the 6 month follow-up visit", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "acute visits", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "62"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "35"}, {"groupId": "OG001", "value": "53"}]}]}]}, {"type": "SECONDARY", "title": "FEV1/FVC", "description": "Forced expiratory volume at one second/forced vital capacity (FEV1/FVC) will be evaluated as a continuous variable. This is a ratio without any units.", "populationDescription": "participants completing the 6 month follow-up visit", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "ratio", "timeFrame": "6 months", "groups": [{"id": "OG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}, {"id": "OG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "63"}, {"groupId": "OG001", "value": "62"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "79.3", "spread": "8.1"}, {"groupId": "OG001", "value": "80.8", "spread": "8.8"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "During the enrollment period, approximately 7 months", "description": "Hospitalizations, including asthma-related hospitalizations, were considered serious adverse events. Participants were asked at each clinic visit about adverse events.", "eventGroups": [{"id": "EG000", "title": "ECS + Medication Group", "description": "The Environmental Control Strategy (\"Home Environmental Intervention\") plus inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nHome Environmental Intervention: Mouse, Cockroach, Furry pets, Dust mites, Smoking, air purifiers, laundered bedding\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist", "deathsNumAffected": 0, "deathsNumAtRisk": 77, "seriousNumAffected": 2, "seriousNumAtRisk": 77, "otherNumAffected": 0, "otherNumAtRisk": 77}, {"id": "EG001", "title": "Medication Group Alone", "description": "inhaled corticosteroids or inhaled corticosteroids plus long-acting beta agonist. (Flovent Diskus or Advair diskus)\n\nFlovent Diskus: Inhaled corticosteroids\n\nAdvair Diskus: inhaled corticosteroids + long-acting beta agonist", "deathsNumAffected": 0, "deathsNumAtRisk": 78, "seriousNumAffected": 10, "seriousNumAtRisk": 78, "otherNumAffected": 0, "otherNumAtRisk": 78}], "seriousEvents": [{"term": "asthma hospitalization", "organSystem": "Respiratory, thoracic and mediastinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 77}, {"groupId": "EG001", "numEvents": 11, "numAffected": 8, "numAtRisk": 78}]}, {"term": "hospitalization", "organSystem": "Psychiatric disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 77}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 78}]}, {"term": "hospitalization", "organSystem": "Gastrointestinal disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 77}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 78}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true, "restrictiveAgreement": false}, "pointOfContact": {"title": "Corinne Keet", "organization": "Johns Hopkins University", "email": "ckeet1@jhmi.edu", "phone": "410-955-5883"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2016-10-03", "uploadDate": "2019-10-14T10:42", "filename": "Prot_SAP_000.pdf", "size": 1248763}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000068297", "term": "Fluticasone-Salmeterol Drug Combination"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000013566", "term": "Sympathomimetics"}, {"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M250", "name": "Fluticasone", "asFound": "Myocardium", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Myocardium", "relevance": "HIGH"}, {"id": "M249", "name": "Fluticasone-Salmeterol Drug Combination", "asFound": "Fabry Disease", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "relevance": "LOW"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}